Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management

BACKGROUND: First described in 1997, breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) was recognised by the World Health Organisation in 2016 as a specific disease. It typically presents as a late seroma-containing atypical, monoclonal T cells which are CD30+ and anaplastic lympho...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleming, Daniel, Stone, Jason, Tansley, Patrick
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945759/
https://www.ncbi.nlm.nih.gov/pubmed/29445921
http://dx.doi.org/10.1007/s00266-017-1064-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945759/
https://www.ncbi.nlm.nih.gov/pubmed/29445921
http://dx.doi.org/10.1007/s00266-017-1064-z

Ejemplares similares